The Center of Disease Control and Prevention (CDC)'s<unk>  guidelines for<unk>  B<unk>  (GBS)<unk>  recommend universal culture-based<unk>  for all pregnant women for vaginal and rectal GBS colonization in order to determine which women should receive intrapartum GBS chemoprophylaxis. CDC recommended that women with unknown GBS colonization status at the time of delivery be managed according to the presence of intrapartum risk factors.  CDC's guidelines recommend<unk>  for vaginal and rectal GBS colonization at 35-37 weeks' gestation.  Swabbing both the lower vagina and rectum (through the anal sphincter) increases the culture yield substantially compared with sampling the cervix or the vagina without also swabbing the rectum.  Routine<unk>  for asymptomatic bacteriuria is recommended in pregnant women, and laboratories should screen urine culture specimens for the presence of GBS in concentrations of 104 colony-forming units (cfu)/ml or greater.
Group B streptococcal infection screening
Neurosyphilis screening
Methicillin resistant staphylococcus aureus screening
Diabetic foot screening
Von Willebrand disease screening
Inflammatory bowel disease screening
Vitamin D deficiency screening
Metabolic syndrome screening